Plain-English translation of NCT05266092 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is trying to understand why people undergoing hemodialysis (a common type of kidney treatment) are so vulnerable to serious blood infections caused by bacteria called Staphylococcus aureus. Researchers believe that the dialysis process itself may weaken the immune system's ability to fight off these infections, and they want to study how blood changes before and after dialysis treatment. By comparing blood samples from dialysis patients with samples from people who have kidney disease but aren't on dialysis, people on a different dialysis method, and healthy volunteers, they hope to find answers.
People on hemodialysis have a very high risk of life-threatening blood infections—about 10% die within 30 days of getting one. Doctors don't fully understand why dialysis patients are so vulnerable to these infections, or whether the dialysis treatment itself makes the problem worse. This study aims to fill that gap so doctors can eventually develop better ways to protect dialysis patients.
You likely qualify if…
You likely don't qualify if…
If you're selected for this study, you'll have blood samples taken before and after your dialysis treatment (or at a single visit if you're in one of the comparison groups). The researchers will analyze your blood to measure inflammation and clotting markers. The study involves no medications or invasive procedures—just blood draws similar to routine kidney disease monitoring. The entire study involves 400 participants across four different groups being compared to each other.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Denmark